BDBM356228 (R or S)-2-fluoro-N-(2-((5- (hydroxymethyl)-2- oxooxazolidin-3-yl)methyl)-4- phenylpyrimidin-5-yl)-5-(1- methyl-1H-pyrazol-3-yl)-4- (trifluoromethyl)benzamide::US9815846, Compound 228
SMILES: Cn1ccc(n1)-c1cc(C(=O)Nc2cnc(CN3CC(CO)OC3=O)nc2-c2ccccc2)c(F)cc1C(F)(F)F
InChI Key: InChIKey=HWPQUWCCLDGBPA-UHFFFAOYSA-N
Data: 1 IC50
Target/Host (Institution) | Ligand | Target/Host Links | Ligand Links | Trg + Lig Links | Ki nM | ΔG° kcal/mole | IC50 nM | Kd nM | EC50/IC50 nM | koff s-1 | kon M-1s-1 | pH | Temp °C |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|
High affinity nerve growth factor receptor (Homo sapiens (Human)) | BDBM356228 ((R or S)-2-fluoro-N-(2-((5- (hydroxymethyl)-2- oxo...) | PDB MMDB UniProtKB/SwissProt B.MOAD DrugBank antibodypedia GoogleScholar AffyNet | PC cid PC sid UniChem | US Patent | n/a | n/a | 0.660 | n/a | n/a | n/a | n/a | n/a | n/a |
Merck Sharp & Dohme Corp. US Patent | Assay Description TrkA functional activity was measured using a DiscoverX PathHunter assay. In this assay, U2OS cells express the human TrkA receptor as a fusion with ... | US Patent US9815846 (2017) BindingDB Entry DOI: 10.7270/Q20P129R | |||||||||||
More data for this Ligand-Target Pair |